Animal Health Market Size, Share & Trends Report

Animal Health Market Size, Share & Trends Analysis Report By Animal Type, By Product, By Distribution Channel (Retail, E-commerce, Hospitals & Clinics), By End Use, And Segment Forecasts, 2019 - 2026

  • Published Date: Feb, 2019
  • Base Year for Estimate: 2018
  • Report ID: GVR-1-68038-763-6
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 325

Industry Insights

The global animal health market size was valued at USD 44.74 billion in 2018 and is expected to witness a CAGR of 5% during the forecast period. The market is largely driven by a significant rise in the zoonotic and food-borne diseases globally. This unprecedented disease prevalence has encouraged companies to produce advanced vaccines and pharmaceuticals. The high demand has also resulted in subsequent rise in the number of companies making consistent efforts to control risks of pathogen contamination and food-borne diseases, which is contributing to market growth.

In addition, rising government initiatives to promote veterinary products is presumed to drive the overall market for animal health. According to the UN Department of Economic and Social Affairs (DESA), the global population is approximately 7.3 billion and is anticipated to reach around 9.7 billion by 2050. Out of this 795 million people are undernourished, as per the estimations of the International Fund for Agricultural Development (IFAD).

North America animal health market

The aforementioned statistics exemplify the urgent requirement to expand food supply through large-scale adoption of livestock. The heightened production of animal-based food products will lead to significant price reduction, facilitating easy access to food at affordable prices. The market is driven by technological advancements in veterinary healthcare, which is anticipated to serve future growth opportunities.

These advancements include advent of efficient information management systems, animal owner mobile technology, and vaccine banks. High focus on innovation in veterinary health has given rise to certain measures that are fueling the market growth prospects. For instance, the Innovative Medicines Initiative (IMI), which is a public-private partnership to support collaborative research to boost innovation in veterinary pharmaceuticals in Europe.

Product Insights

Feed additive segment held a dominant market share of 39.05% in 2018, owing to consistent advancements in the products. Feed additive are bifurcated into nutritional and medicinal. Product advancements in the segment predominantly include the use of metabolic modifiers, enzymes, minerals, and probiotics. These additives facilitate significant increase in muscle growth, thereby optimizing feed utilization.

In addition, high inclination of government healthcare organizations toward enhancement of agricultural practices and veterinary health is presumed to be responsible for the segment growth. For instance, certain additives are permitted and recommended by the European Union to use in feed. These additives include vitamins, antioxidants, and performance promoters.

Distribution Channel Insights

Veterinary hospitals and clinics segment accounted for the dominant market share in 2018. Increasing number of hospital pharmacies coupled with high procedural volume as a consequence of frequent readmission of pets for treatment have supported the segment growth. Retail channels and E-commerce platform held a significant market share during the same year. The growth can be attributed to the factors, such as high convenience and increasing number of retail pharmacies among others.

Retail pharmacies segment is expected to expand at a moderate CAGR throughout the forecast period. Major manufacturers rely on only licensed veterinarians and authorized distributors for the distribution of medications and vaccines. This factor is projected to positively influence the segment growth in the forthcoming years.

E-commerce/online pharmacies is anticipated to witness exponential growth throughout the forecast period. This growth is believed to be a result of various advantages, such as increased convenience for patients unwilling to purchase medicines from retail or hospital pharmacies. These benefits are anticipated to accentuate the demand for e-commerce throughout the forecast period.

End Use Insights

Increase in incidence of zoonotic diseases caused by globalization and climate changes are expected to drive the demand for diagnostic procedures, which is expected to drive growth of the point-of-care testing/in-house testing in the forthcoming years. Increase in initiatives to create awareness among pet owners about the benefits of preventive care for pets is one of the key contributing factors for the growth of the segment. Tests such as ELISA have been proven effective for heartworm diagnosis.

Availability of a wide range of treatment as well as diagnostic options in veterinary hospitals and clinics is a high impact rendering factor for this segment. Veterinary hospitals and clinics accounted for the largest share of the end use segment in 2018. The dominant share captured by this segment is also a consequence of various applications, such as clinical pathology, toxicology tests, and therapy.

Certain vaccines are only available in accredited veterinary hospitals and clinics responsible for boosting the share of veterinary hospitals and clinics in the end use segment. Various government animal welfare organizations have issued guidelines for safety practices and standards to be implemented in veterinary hospitals and clinics, which has broadened the scope for segment growth over the past few years.

Animal Type Insights

Production animal segment held the leading market share in 2018. The substantial share captured by the segment can be presumed as a consequence of high concern for food safety and sustainability by government healthcare organizations globally. Policymakers in various countries are striving to achieve total food security, which propels large-scale food production and results in greater rearing of livestock.

Global animal health market

The policies focus on long-term sustainability, which can be achieved through a combination of improving productivity and greater attention to livestock veterinary healthcare. According to the Food and Agriculture Organization (FAO), in the emerging economies, animal-based food products account for one-third of human protein consumption, leading to an increase in livestock productivity, which is critical to meet dietary needs of the growing human population. These factors cumulatively are responsible for the significant share captured by production animals in this segment.

Regional Insights

North America captured substantial share of the global companion animal health market in 2018, owing to the wide range of definitive measures adopted by government animal welfare organizations that are consistently working for overall improvement in animal health. Furthermore, technological advancements, prevalence of zoonotic diseases, and increasing number of pet owners is expected to boost the regional growth. Several collaborative efforts undertaken by major companies to enhance their R&D capabilities and to ensure high quality standards are anticipated to impel the demand further across this region. Moreover, the high disease burden can also be attributed to the regional growth.

On the other hand, Asia Pacific market is expected to expand at a lucrative CAGR over the forthcoming years. The high growth is believed to be a consequence of consistent R&D investments deployed by the prominent players and their efforts to commercialize branded and generic therapeutics at a relatively inexpensive price. The exponential growth can also be accredited to high awareness pertaining to pet nutrition and supplies and rising disposable income.

Animal Health Market Share Insights

The market is marked by extensive regional expansion strategies, mergers and acquisitions, and collaborative research initiatives undertaken by the major market players. For instance, In January 2018, Zoetis aquaculture division, PHARMAQ acquired Norland Sett Vaks to increase its product portfolio for vaccines.

In March 2018, Merck completed the acquisition of Vallee S.A. This acquisition was carried out to expand the company’s animal health product portfolio and enhance its presence in Brazil. In another instance, in December 2016, Bayer AG entered into an agreement with Boehringer Ingelheim Vetmedica, Inc. (BIVI) to acquire BIVI’s Cydectin ovine and bovine endectocide products. This acquisition was carried out to widen the former’s product portfolio.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2017

Forecast period

2019 - 2026

Market representation

Revenue in USD Million and CAGR from 2019 to 2026

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, Germany, U.K., France, Italy, Russia, Spain, Netherlands, Switzerland, Sweden, Ireland, Poland, Japan, China, India, Indonesia, Thailand, Australia, South Korea, Philippines, Malaysia, Singapore, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Turkey, Iran, United Arab Emirates, Israel

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global animal health market report on the basis of animal type, product, distribution channel, end use, and region:

  • Animal Type Outlook (Revenue, USD Million, 2014 - 2026)

    • Production Animal

      • By Type

        • Poultry

        • Swine

        • Cattle

        • Sheep & Goats

        • Fish

      • By Product

        • Vaccines

        • Pharmaceuticals

        • Feed Additives

        • Diagnostics

        • Others

    • Companion Animal

      • By Type

        • Dogs

        • Cats

        • Horses

        • Others

      • By Product

        • Vaccines

        • Pharmaceuticals

        • Feed Additives

        • Diagnostics

        • Others

  • Product Outlook (Revenue, USD Million, 2014 - 2026)

    • Vaccines

      • Live Attenuated Vaccines

      • DNA Vaccines

      • Recombinant Vaccines

      • Inactivated Vaccines

      • Others

    • Pharmaceuticals

      • Parasiticides

      • Anti-infectives

      • Anti-inflammatory

      • Analgesics

      • Others

    • Feed Additives

      • Nutritional

      • Medicinal

    • Diagnostics

      • Instruments

      • Consumables

    • Others

  • Distribution Channel Outlook (Revenue, USD Million, 2014 - 2026)

    • Retail

    • E-commerce

    • Veterinary Hospitals & Clinics

  • End Use Outlook (Revenue, USD Million, 2014 - 2026)

    • Reference Laboratories

    • Point-of-care Testing/In-house Testing

    • Veterinary Hospitals & Clinics

    • Others

  • Regional Outlook (Revenue, USD Million, 2014 - 2026)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Russia

      • Spain

      • Netherlands

      • Switzerland

      • Sweden

      • Ireland

      • Poland

    • Asia Pacific

      • Japan

      • China

      • India

      • Indonesia

      • Thailand

      • Australia

      • South Korea

      • Philippines

      • Malaysia

      • Singapore

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • Turkey

      • Iran

      • United Arab Emirates

      • Israel

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified